Altium Capital Management’s Olema Oncology OLMA Stock Holding History
Bought
Maintained
Sold
Other funds holding OLMA
Altium Capital Management's OLMA Position: Q2 2024 in Review
Altium Capital Management sold out of Olema Oncology (OLMA) in Q2 2024, closing a stake of 605,000 shares — an estimated $6.85M sold.
Altium Capital Management first reported a position in OLMA in Q2 2023 and held it in 4 quarters. The position peaked at $6.85M in Q1 2024. 129 funds tracked by Wall St. Rank hold OLMA as of Q2 2024.
- Altium Capital Management reported no remaining Olema Oncology position as of Q2 2024 after selling out during the quarter.
- Altium Capital Management sold 605,000 Olema Oncology shares in Q2 2024, an estimated $6.85M.
- Altium Capital Management first reported a position in Olema Oncology in Q2 2023 and held it in 4 quarters.
- Altium Capital Management's Olema Oncology position peaked at $6.85M in Q1 2024.
- 129 funds tracked by Wall St. Rank held Olema Oncology as of Q2 2024.
Based on Altium Capital Management's 13F filing for Q2 2024, filed 15 Aug 2024.